Esports Entertainment Group’s VIE.bet Esports Betting Brand Named Primary Sponsor of Brazil’s SG esports

 

Newark, New Jersey–(Newsfile Corp. – August 30, 2021) – Esports Entertainment Group, Inc. (NASDAQ: GMBL) (NASDAQ: GMBLW) (or the “Company”), an esports entertainment and online gambling company, announced today that their VIE.bet esports betting brand has become official partners of SG esports, a Brazilian professional gaming organization. SG esports will don the VIE logo as their primary jersey sponsor throughout the partnership, which includes The International 10 in October, with a prize pool of $40 million.

“We are excited to announce this partnership with SG Esports. The organization and their team has done a great job qualifying for The International this October,” said Bux Syed, Director of VIE.bet. “We’re looking forward to working closely with SG Esports to further expand our growth in Brazil and the rest of Latam.”

The partnership consists of two Dota 2 teams, a CSGO team and SG esports’ entire influencer/streamer roster.

“We are honored to share a long-term partnership with Esports Entertainment Group and their Vie.bet brand,” said Mateus Cysne Barbosa, CEO of SG esports. “Vie.bet represents what we want for the world of betting and electronic sports — professionalism and transparency. These are the qualities we look for in our partners.”

Brazil is the number three country in the world in terms of Esports enthusiasts with an estimated 12.6 million in 2021.

About Esports Entertainment Group

Esports Entertainment Group is a full stack esports and online gambling company fueled by the growth of video-gaming and the ascendance of esports with new generations. Our mission is to help connect the world at large with the future of sports entertainment in unique and enriching ways that bring fans and gamers together. Esports Entertainment Group and its affiliates are well-poised to help fans and players to stay connected and involved with their favorite esports. From traditional sports partnerships with professional NFL/NHL/NBA/FIFA teams, community-focused tournaments in a wide range of esports, and boots-on-the-ground LAN cafes, EEG has influence over the full-spectrum of esports and gaming at all levels. The Company maintains offices in New Jersey, the UK and Malta. For more information visit www.esportsentertainmentgroup.com.

FORWARD-LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

Contact:
U.S. Investor Relations
RedChip Companies, Inc.
Dave Gentry
407-491-4498
dave@redchip.com

Media & Investor Relations Inquiries
Jeff@esportsentertainmentgroup.com

ACCO Brands Strengthens Leadership to Fuel Growth

 

Names Tedford President and Chief Operating Officer; Hires Bernstein to lead North America Segment

LAKE ZURICH, Ill.–(BUSINESS WIRE)– ACCO Brands Corporation (NYSE: ACCO) today announced that Tom Tedford, currently Executive Vice President and President, ACCO Brands North America, has been named President and Chief Operating Officer, effective September 1, 2021. In his new role, Tedford will have full responsibility for the sales, marketing and operations of all the company’s businesses and products worldwide, and will continue to report to Boris Elisman, Chairman and Chief Executive Officer.

“Under Tom’s leadership, ACCO Brands North America has successfully managed channel, product line and technology transitions, as well as trade wars and pandemic-related challenges,” said Elisman. “During his stewardship, we gained share in our core brands, grew sales in consumer-oriented channels, maintained strong operating margins, and won several ‘Best Employer’ and ‘America’s Safest Company’ awards. His track record of success, coupled with his deep understanding of our business, will serve us well as he takes on his new global responsibilities,” Elisman continued.

“I am very excited to take on this new role and accelerate the strategic transformation of our business toward faster growing consumer-centric categories,” said Tedford. “We have tremendous opportunities for growth worldwide, both in our existing categories, as the world recovers from the pandemic, and in new categories, as we expand our recently acquired PowerA business to new customers and geographies.”

ACCO Brands also announced that Roxanne Bernstein will join the Company on September 7 as Executive Vice President and President, ACCO Brands North America. Bernstein has deep and broad experience in marketing, strategy and general management in consumer and food businesses. Most recently, she served as President of Crystal Farms Dairy Company, a subsidiary of Post Holdings. Bernstein has held management positions of increasing responsibilities with Post Consumer Brands, Heritage Home Group, Cessna Aircraft Company and Kraft Foods. She has a Bachelor of Science degree from the United States Military Academy and earned a Master of Business Administration degree from Colorado State University.

About ACCO Brands Corporation

ACCO Brands Corporation (NYSE: ACCO) is one of the world’s largest designers, marketers and manufacturers of branded academic, consumer and business products. Our widely recognized brands include Artline®, AT-A-GLANCE®, Barrilito®, Derwent®, Esselte®, Five Star®, Foroni®, GBC®, Hilroy®, Kensington®, Leitz®, Mead®, PowerA®, Quartet®, Rapid®, Rexel®, Swingline®, Tilibra®, Wilson Jones® and many others. Our products are sold in more than 100 countries around the world. More information about ACCO Brands, the Home of Great Brands Built by Great People, can be found at www.accobrands.com.

Christine Hanneman
Investor Relations
(847) 796-4320

Julie McEwan
Media Relations
(937) 974-8162

Source: ACCO Brands Corporation

Monday, August 30, 2021

Item 9 Labs Corp (INLB)
$19 million Construction-Financing Loan for Arizona and Nevada Expansion

Item 9 Labs Corp. (OTCQX: INLB) is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The award-winning Item 9 Labs brand specializes in best-in-class products and user experience across several cannabis categories. The company also offers a unique dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. Item 9 Labs brings the best industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation. The veteran management team combines a diverse skill set with deep experience in the cannabis sector, franchising, and the capital markets to lead a new generation of public cannabis companies that provide transparency, consistency, and well-being. Headquartered in Arizona, the company is currently expanding its operations space by 650,000+ square feet on its 50-acre site, one of the largest properties in Arizona zoned to grow and cultivate flower. For additional information, visit item9labscorp.com.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Construction Loan.  Late last week, Item 9 Labs entered into a $19 million construction-financing loan with Pelorus Equity Group, a leading provider of value-add bridge commercial real estate loans to cannabis businesses. The loan is a significant step in Item 9 Labs’ strategy to build out its cultivation capabilities in the fast growing Arizona and Nevada markets.


Use of Proceeds.   The proceeds will be used to finance the acquisition of 44 acres of adjacent land next to Item 9 Labs’ current 19,200 sq. ft. facility in Arizona and be used to finance the master site development. The Phase 1 expansion will add 9,600 sq. ft. for indoor cultivation, 9,600 sq. ft. of lab and packaging, and a 9,600 sq. ft. head house to support the addition of …

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Monday, August 30, 2021

1-800-Flowers.com (FLWS)
Keeping What It Got And Then Some

1-800-FLOWERS.COM, Inc. is the leading provider of gourmet and floral gifts for all occasions. For nearly 40 years, 1-800-FLOWERS® has been helping deliver smiles for customers with gifts for every occasion, including fresh flowers, premium, gift-quality fruits, and other gourmet items from Harry & David®, popcorn and specialty treats from The Popcorn Factory®; cookies and baked gifts from Cheryl’s®; premium chocolates and confections from Fannie May®; gift baskets and towers from 1-800-Baskets.com®; premium English muffins and other breakfast treats from Wolferman’s; carved fresh fruit arrangements from FruitBouquets.com; and top quality steaks and chops from Stock Yards®. The Company’s BloomNet® international floral wire service provides a broad range of quality products and value-added services designed to help professional florists grow their businesses profitably.

Michael Kupinski, Director of Research, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Fiscal Q4 results in line with expectations on strong revenue growth. Total company revenues increased a solid 16.6% to $486.9 million, better than our $472.0 million estimate. The revenue performance was notable given that it was on top of the 61% revenue growth in the prior year quarter, which benefited from enhanced ecommerce growth during the height of the Covid pandemic. Adjusted EBITDA of $30.2 million was in line with expectations.


Favorable foundation for growth.  We believe that the enhanced revenues during Covid set the stage for favorable revenue growth going forward as the company markets to the new customers, increases its loyalty based customers, Passport, and develops new products …

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Wednesday, August 25, 2021

Schwazze (SHWZ)
The Acquisition Beat Goes On

Medicine Man Technologies, Inc. is now operating under its new trade name, Schwazze. Schwazze is executing its strategy to become a leading vertically integrated cannabis holding company with a portfolio consisting of top-tier licensed brands spanning cultivation, extraction, infused-product manufacturing, dispensary operations, consulting, and a nutrient line. Schwazze leadership includes Colorado cannabis leaders with proven expertise in product and business development as well as top-tier executives from Fortune 500 companies. As a leading platform for vertical integration, Schwazze is strengthening the operational efficiency of the cannabis industry in Colorado and beyond, promoting sustainable growth and increased access to capital, while delivering best-quality service and products to the end consumer. The corporate entity continues to be named Medicine Man Technologies, Inc.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

More Cultivation Expansion. Schwazze has entered into an agreement to acquire the assets of Brow 2 LLC. Denver-based Brow 2 operates a 37,000 sq. ft. building, including 27,000 sq. ft. of canopy, for indoor cultivation and related equipment. Brow 2 adds high-quality flower cultivation capacity and new strain genetics to Schwazze’s portfolio. The price for the acquisition is $6.7 million to be paid in cash at closing, which is expected before the end of the third quarter of 2021.


More to Come? We believe Schwazze will continue to target expansion on the cultivation side as ownership of production provides the Company with a controlled source of differentiated product for both its retail and wholesale operations as well as a better overall margin profile than outsourced product.  Schwazze’s integrated operating capabilities provide a cost advantage over mom and pop operators …

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Schwazze Signs Definitive Agreement to Acquire Colorado Cultivation Grower Brow 2, LLC

 

DENVER, Aug. 23, 2021 /PRNewswire/ – Schwazze, (OTCQX: SHWZ) (“Schwazze” or the “Company”), has entered into an to agreement to acquire the assets of Brow 2, LLC, located in Denver, Colorado.  The planned transaction includes a 37,000 square foot building (27,000 square feet of canopy) for indoor cultivation and equipment. This transaction continues Schwazze’s aggressive expansion in Colorado and will significantly enhance the Company’s cultivation resources, providing product directly to its seventeen Star Buds brand dispensaries.

The consideration for the planned acquisition is $6.7 million and will be paid in cash at closing. The acquisition is expected to close in the third quarter of 2021 after the Colorado Marijuana Enforcement Division and local licensing approval.

“We are looking forward to adding the Brow team to the growing Schwazze family. This acquisition will add a talented team of growers, high-quality indoor flower cultivation capacity, new strain genetics, and another profitable asset to our platform. The new facility will supply our growing network of dispensaries and customers with a broad assortment of high-quality indoor flower,” said Justin Dye, Schwazze’s CEO.  

About Schwazze

Schwazze (OTCQX: SHWZ) is the parent company of a portfolio of vertically integrated cannabis brands spanning seed to sale. The company’s intent is to apply its operational playbook by expanding into markets where it can entrench itself in a leadership position. Anchored by a high-performance culture, Schwazze focuses on growth by purposeful design, combining customer-centric thinking and data science to test, measure, and drive desired outcomes. The company’s leadership team has deep expertise in CPG, retail, and building consumer brands at Fortune 500 companies as well as in the cannabis sector. Schwazze is passionate about improving the human condition; making a difference in our communities; promoting diversity and inclusion; and doing its part to incorporate climate-conscious best practices.

Schwazze derives its name from the pruning technique of a cannabis plant to promote growth. Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc.

Forward-Looking Statements

This press release contains “forward-looking statements.” Such statements may be preceded by the words “may,” “will,” “plan,” “predicts,” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; (v) difficulties in securing regulatory approval to market our products and product candidates; (vi) our ability to successfully execute our growth strategy in Colorado and outside the state, (vii) our ability to consummate the acquisition described in this press release or to identify and consummate future acquisitions that meet our criteria, (viii) our ability to successfully integrate acquired businesses and realize synergies therefrom, (ix) the ongoing COVID-19 pandemic, * the timing and extent of governmental stimulus programs, and (xi) the uncertainty in the application of federal, state and local laws to our business, and any changes in such laws. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.

SOURCE Medicine Man Technologies, Inc.

Schwazze Signs Definitive Agreement to Acquire Colorado Cultivation Grower Brow 2, LLC

 

DENVER, Aug. 23, 2021 /PRNewswire/ – Schwazze, (OTCQX: SHWZ) (“Schwazze” or the “Company”), has entered into an to agreement to acquire the assets of Brow 2, LLC, located in Denver, Colorado.  The planned transaction includes a 37,000 square foot building (27,000 square feet of canopy) for indoor cultivation and equipment. This transaction continues Schwazze’s aggressive expansion in Colorado and will significantly enhance the Company’s cultivation resources, providing product directly to its seventeen Star Buds brand dispensaries.

The consideration for the planned acquisition is $6.7 million and will be paid in cash at closing. The acquisition is expected to close in the third quarter of 2021 after the Colorado Marijuana Enforcement Division and local licensing approval.

“We are looking forward to adding the Brow team to the growing Schwazze family. This acquisition will add a talented team of growers, high-quality indoor flower cultivation capacity, new strain genetics, and another profitable asset to our platform. The new facility will supply our growing network of dispensaries and customers with a broad assortment of high-quality indoor flower,” said Justin Dye, Schwazze’s CEO.  

About Schwazze

Schwazze (OTCQX: SHWZ) is the parent company of a portfolio of vertically integrated cannabis brands spanning seed to sale. The company’s intent is to apply its operational playbook by expanding into markets where it can entrench itself in a leadership position. Anchored by a high-performance culture, Schwazze focuses on growth by purposeful design, combining customer-centric thinking and data science to test, measure, and drive desired outcomes. The company’s leadership team has deep expertise in CPG, retail, and building consumer brands at Fortune 500 companies as well as in the cannabis sector. Schwazze is passionate about improving the human condition; making a difference in our communities; promoting diversity and inclusion; and doing its part to incorporate climate-conscious best practices.

Schwazze derives its name from the pruning technique of a cannabis plant to promote growth. Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc.

Forward-Looking Statements

This press release contains “forward-looking statements.” Such statements may be preceded by the words “may,” “will,” “plan,” “predicts,” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; (v) difficulties in securing regulatory approval to market our products and product candidates; (vi) our ability to successfully execute our growth strategy in Colorado and outside the state, (vii) our ability to consummate the acquisition described in this press release or to identify and consummate future acquisitions that meet our criteria, (viii) our ability to successfully integrate acquired businesses and realize synergies therefrom, (ix) the ongoing COVID-19 pandemic, * the timing and extent of governmental stimulus programs, and (xi) the uncertainty in the application of federal, state and local laws to our business, and any changes in such laws. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.

SOURCE Medicine Man Technologies, Inc.

Monday, August 23, 2021

Item 9 Labs Corp (INLB)
Record Quarterly Revenue in 3Q21

Item 9 Labs Corp. (OTCQX: INLB) is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The award-winning Item 9 Labs brand specializes in best-in-class products and user experience across several cannabis categories. The company also offers a unique dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. Item 9 Labs brings the best industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation. The veteran management team combines a diverse skill set with deep experience in the cannabis sector, franchising, and the capital markets to lead a new generation of public cannabis companies that provide transparency, consistency, and well-being. Headquartered in Arizona, the company is currently expanding its operations space by 650,000+ square feet on its 50-acre site, one of the largest properties in Arizona zoned to grow and cultivate flower. For additional information, visit item9labscorp.com.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

3Q21 Results. Item 9 reported record quarterly revenue of $6.7 million in the fiscal third quarter, up 203% from 3Q20. Revenue was up 9.5% sequentially. This marks seven consecutive quarters of revenue growth. Net loss declined to $833,905, or $0.01 per share, compared to a net loss of $1.6 million, or $0.03 per share last year. We had projected revenue of $6.5 million and net income of $300,000 or breakeven EPS.


Solid Market Position.  Item 9 Labs products have earned a solid position in the Arizona marketplace as the top brand in every dispensary the Company chooses to sell through, according to Leaf Link. Currently, at the end of the quarter, Item 9 Labs products were being sold in 79, or 64% of Arizona’s dispensaries, up from 45, or 37% at the end of June 2020. As the Company continues to add …

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Monday, August 23, 2021

Bassett Furniture (BSET)
Call With Management On Business Conditions

Bassett Furniture Industries, Inc. is a leading manufacturer and marketer of high-quality home furnishings. With 96 company- and licensee-owned stores located throughout the United States, Bassett has leveraged its strong brand name in furniture into a network of corporate and licensed stores that focus on providing consumers with a friendly environment for buying furniture and accessories. Bassett’s retail strategy includes stylish, custom-built furniture that features the latest on-trend furniture styles, free in-home design visits, and coordinated decorating accessories. The Company also has a traditional wholesale business with more than 700 accounts on the open market and a logistics business specializing in the transport and warehousing of home furnishings. In addition, Bassett sells its products through its website at www.bassettfurniture.com. With revenues in excess of $450 million, approximately 75% of its goods are manufactured, assembled and/or finished in factories located in Virginia, North Carolina and Alabama with the remainder primarily sourced from Asia. The Company was founded in 1902 and is based in Bassett, Virginia.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Management Call. We were able to speak with CFO Michael Daniel regarding the Company’s recent press release on current business conditions. The biggest challenge, one affecting many industries, is finding labor, and then keeping labor. The lack of labor supply is rippling throughout the organization, increasing cost pressure. Bassett also continues to receive additional cost increases from vendors which will negatively impact wholesale margins for the third quarter and likely will result in a fourth price increase this year.


COVID Rears Again.  In addition, the recent resurgence of COVID in Asia has caused some suppliers to temporarily cease operations. The Company sources a significant amount of its bedroom and formal dining room furniture and certain component parts for manufacturing operations from Asia, particularly Vietnam …

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Schwazze Announces Star Buds Colorado Home Delivery Services

 

Star Buds Cannabis Delivery Services Launch in the City of Aurora

DENVER, Aug. 19, 2021 /PRNewswire/ – Schwazze, (OTCQX:SHWZ) (“Schwazze” or the “Company”), announces the launch of its cannabis product home delivery service to residences in the city of Aurora beginning today.  Aurora home delivery service will start from its Star Buds Montview retail dispensary location at 10100 E. Montview Boulevard. Orders may be placed online at https://www.starbuds.us/colorado with an option to select home delivery services for those residing in the Aurora area. The delivery service is available to any personal residences located within the city limits of Aurora, in which the Star Buds Montview location currently serves.

The launch of the delivery service from Star Buds Montview is the first phase of a home delivery offering for the Star Buds dispensaries in Colorado. The second phase, expected later this year, will include deliveries from the Star Buds Arapahoe location at 14655 E. Arapahoe Road, also based in Aurora.

“We are excited to meet our Star Buds’ customers when and where they want to shop. We see this as a positive step forward to bring the best selection of high-quality flower and CPG cannabinoid products to more Colorado households. Our goal is to make cannabis products even more accessible through the convenience of home delivery and make it readily available to a greater number of people than ever before,” said Nirup Krishnamurthy, COO of Schwazze.  

About Schwazze
Schwazze (OTCQX: SHWZ) is building the premier vertically integrated cannabis company in Colorado and plans to take its operating system to other states where it can develop a differentiated leadership position.  Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale. The Company is committed to unlocking the full potential of the cannabis plant to improve the human condition.  Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector.  Schwazze is passionate about making a difference in our communities, promoting diversity and inclusion, and doing our part to incorporate climate-conscious best practices.  Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc.

Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth.

Forward-Looking Statements
This press release contains “forward-looking statements.” Such statements may be preceded by the words “plan,” “will,” “may,”, “predicts,” or similar words. Forward-looking statements are not guarantees of future events or performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual events and results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; (v) difficulties in securing regulatory approval to market our products and product candidates; (vi) our ability to successfully execute our growth strategy in Colorado and outside the state, (vii) our ability to consummate the acquisition described in this press release or to identify and consummate future acquisitions that meet our criteria, (viii) our ability to successfully integrate acquired businesses and realize synergies therefrom, ({ix) the ongoing COVID-19 pandemic, * the timing and extent of governmental stimulus programs, and (xi) the uncertainty in the application of federal, state and local laws to our business, and any changes in such laws. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.

SOURCE Medicine Man Technologies, Inc.

Schwazze Announces Star Buds Colorado Home Delivery Services

 

Star Buds Cannabis Delivery Services Launch in the City of Aurora

DENVER, Aug. 19, 2021 /PRNewswire/ – Schwazze, (OTCQX:SHWZ) (“Schwazze” or the “Company”), announces the launch of its cannabis product home delivery service to residences in the city of Aurora beginning today.  Aurora home delivery service will start from its Star Buds Montview retail dispensary location at 10100 E. Montview Boulevard. Orders may be placed online at https://www.starbuds.us/colorado with an option to select home delivery services for those residing in the Aurora area. The delivery service is available to any personal residences located within the city limits of Aurora, in which the Star Buds Montview location currently serves.

The launch of the delivery service from Star Buds Montview is the first phase of a home delivery offering for the Star Buds dispensaries in Colorado. The second phase, expected later this year, will include deliveries from the Star Buds Arapahoe location at 14655 E. Arapahoe Road, also based in Aurora.

“We are excited to meet our Star Buds’ customers when and where they want to shop. We see this as a positive step forward to bring the best selection of high-quality flower and CPG cannabinoid products to more Colorado households. Our goal is to make cannabis products even more accessible through the convenience of home delivery and make it readily available to a greater number of people than ever before,” said Nirup Krishnamurthy, COO of Schwazze.  

About Schwazze
Schwazze (OTCQX: SHWZ) is building the premier vertically integrated cannabis company in Colorado and plans to take its operating system to other states where it can develop a differentiated leadership position.  Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale. The Company is committed to unlocking the full potential of the cannabis plant to improve the human condition.  Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector.  Schwazze is passionate about making a difference in our communities, promoting diversity and inclusion, and doing our part to incorporate climate-conscious best practices.  Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc.

Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth.

Forward-Looking Statements
This press release contains “forward-looking statements.” Such statements may be preceded by the words “plan,” “will,” “may,”, “predicts,” or similar words. Forward-looking statements are not guarantees of future events or performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual events and results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; (v) difficulties in securing regulatory approval to market our products and product candidates; (vi) our ability to successfully execute our growth strategy in Colorado and outside the state, (vii) our ability to consummate the acquisition described in this press release or to identify and consummate future acquisitions that meet our criteria, (viii) our ability to successfully integrate acquired businesses and realize synergies therefrom, ({ix) the ongoing COVID-19 pandemic, * the timing and extent of governmental stimulus programs, and (xi) the uncertainty in the application of federal, state and local laws to our business, and any changes in such laws. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.

SOURCE Medicine Man Technologies, Inc.

Wednesday, August 18, 2021

Stem Holdings, Inc. (STMH)(STEM:CA)
Moving Forward With the Farm-to-Home Strategy; Reports 3Q21 Results

Stem Holdings Inc is engaged in the purchasing, improving, and leasing of properties and finance assets which are operated by third parties and are used for the cultivation and retail sale of marijuana. Its properties includes 42nd Street, and Mulino Farm which are used for agriculture. The company generates its revenue in the form of rental income from tenants.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

3Q2021 Results. Stem reported third quarter record gross sales of $12.4 million and net sales of $10.6 million, a 104% increase and 103% increase, respectively, over the prior year’s $6.1 million gross sales and $5.2 million net sales. Gross margin was 14%, compared with 34% in the prior year period, due to reclassification of expenses. We had forecast net revenue of $12.75 million.


Positive EPS, But.  Stem recorded net income of $2.7 million in the third quarter, or EPS of $0.01. This compares to a loss of $826,000, or a loss of $0.01 per share, in the same period last year. The positive net income was the result of a $6.4 million change in fair value of warrant liability. Excluding the warrant liability gain, we estimate Stem would have reported a net loss of $3.8 million in …

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

 

Stem Holdings, Inc. d/b/a Driven By Stem Announces Record Sales and Gross Margin for the Third Quarter

 

BOCA RATON, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) — Stem Holdings, Inc. d/b/a Driven by Stem (OTCQX: STMH) (CSE: STEM) (the “Company” or “Stem“), the first multi-state, vertically integrated Farm-to-Home^™ (F2H) cultivation and technology omnichannel cannabis company featuring a proprietary Delivery-as-a-Service (DaaS) marketplace platform, today reported results for the third fiscal quarter ended June 30, 2021. Stem reported third quarter record gross sales of US$12.4 million and net sales of US$10.6 million, a 104% increase and 103% increase, respectively, over the prior year’s US$6.1 million gross sales and US$5.2 million net sales. Gross margin improved 7.6% to 41.8%, reflecting improvements in productivity, mix, and synergies from the Company’s acquisition of Driven Deliveries, Inc.

“I am proud of our results, and of our team which is executing our robust four-point plan for growth,” stated Adam Berk, Chief Executive Officer. “We are building our footprint with a strong ongoing focus on cost reductions, operational excellence, and customer acquisition and retention to drive topline sales and margin improvement as we did this quarter,” he continued. “Most importantly, we are uniquely connecting our brands, products and delivery services with the cannabis community from Farm to Home™ for long-term stability. We expect to achieve longer-term benefits that will build value for our shareholders as we invest in organic and acquisitive growth,” Berk concluded.

Stem is also reporting a 19% increase in total dispensary sales, a significant outperform to market particularly in Oregon which grew at 7% in the same period. This reflects continuous improvement initiatives and emphasis on customer service. This effort dovetailed with the launch of the company’s Budee™ delivery platform in Oregon which occurred on August 9, 2021. A customized app was built from front-to-back for this official launch, and Budee™ is now anchored by Stem’s TJ’s on Powell dispensary servicing the Greater Metro Portland area. The Company expects that Budee™ will expand to cover the majority of Oregon beginning with the Eugene metro in October 2021. In addition, Budee™ continues to increase its penetration of the California delivery market where it originated. It now covers 92% of that state’s population particularly in areas where there is high demand and a low density of dispensaries.

Stem also expects to launch its first dispensary in Michigan in September 2021, which will be coupled with Budee™ delivery, as the next step in the Company’s “Get Ready” retail expansion strategy.

As Stem builds its Farm-to-Home™ infrastructure with vertical integration from cultivation to delivery, the Company has also invested in expanding its canopy for high-quality cannabis growth, particularly at its Mulino, Oregon farm and its newest facility in Springfield, Oregon. All five Stem cultivation facilities in Oregon are growing core and new genetics to delight customers and build loyalty. Stem’s extraction lab which now includes solventless extraction is supporting both Stem’s edibles and concentrates, two sectors that are both growing and margin-accretive. Stem’s products are now sold in over 240 dispensaries outside of Stem branded stores.

Stem will host a conference call to discuss the financial results on Tuesday, August 17, 2021 at 8:00 am as previously announced.

Conference Details

Management plans to host a conference call to discuss the financial results on Tuesday, August 17, 2021 at 8:00 a.m. EDT.

About Stem Holdings

Stem Holdings is a leading omnichannel, vertically-integrated cannabis branded products and technology company with state-of-the-art cultivation, processing, extraction, retail, distribution, and delivery-as-a-service (DaaS) operations throughout the United States. Stem’s family of award-winning brands includes TJ’s Gardens™, TravisxJames™, and Yerba Buena™ flower and extracts; Cannavore™ edible confections; Doseology™, a CBD mass-market brand launching in late 2021; as well as DaaS brands Budee™ and Ganjarunner™ through the acquisition of Driven Deliveries. Budee™ and Ganjarunner™ e-commerce platforms provide direct-to consumer proprietary logistics and an omnichannel UX (user experience)/CX (customer experience).

Forward-Looking Statements 
This press release contains forward-looking statements and information that are based on the beliefs of management and reflect the Company’s current expectations.  When used in this press release, the words “estimate”, “project”, “belief”, “anticipate”, “intend”, “expect”, “plan”, “predict”, “may” or “should” and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. The forward-looking statements and information in this press release includes information relating to: (i) the implementation of the Company’s business plan; (ii) the expansion of Stem’s brands, retail footprint, delivery services and products into other markets, including Michigan; (iii) expected impact of the Company’s extraction lab; (iv) the expected launch of new brands and products by Stem; and (v) expected organic and acquisitive growth. 

By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.  Such factors include, among others, the following risks: risks associated with the implementation of the Company’s business plan and matters relating thereto, risks associated with the cannabis industry, competition, regulatory change, the need for additional financing, reliance on key personnel, the potential for conflicts of interest among certain officers or directors, insurance, intellectual property and reliable supply chains; and risks related to the Company and its business generally. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made, and the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change.  Investors are cautioned against attributing undue certainty to forward-looking statements.

Stem Holdings 
Investor Relations Contact: 
KCSA Strategic Communications 
Valter Pinto or Elizabeth Barker 
+1 212.896.1254 or +1 212.896.1203 
valter@kcsa.com or ebarker@kcsa.com

Media Contact: 
Mauria Betts 
Director of Branding and Public Relations 
971.266.1908 
mauria@stemholdings.com